GTC Biotherapeutics (fka GTCB)

[go seek]

LEO Pharma is a global leader within dermatology, with a strong focus on the development, production and marketing of drugs for the treatment of psoriasis and other skin diseases.

LEO (charitable trust) may have decided to move more towards dermatological products. It seems like dermatology is more LEO's focus than is critical care when one reads their web page (or ATryn did not work as they expected...)

Or another unknown reason for the jettison